EV/EBITDA:
-8.92-0.78(-9.58%)Summary
- As of today (August 26, 2025), CGON EV/EBITDA is -8.92, with a fall of -0.78 (-9.58%) during the most recent trading session on August 26, 2025.
- Over the past year, CGON EV/EBITDA has increased by +20.33 (+69.50%).
- CGON EV/EBITDA is now -139.14% below its all-time high of -3.73.
Performance
CGON EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
CGON EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | -9.6% | +9.6% | +6.3% |
| 1 m1 month | -5.4% | +5.4% | +3.6% |
| 3 m3 months | +4.3% | +11.9% | +6.3% |
| 6 m6 months | +12.6% | +19.8% | +7.7% |
| ytdytd | +29.1% | -2.9% | -5.8% |
| 1 y1 year | +69.5% | -29.2% | -28.4% |
| 5 y5 years | - | - | - |
CGON EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -7.42 | -20.2% | -8.92 | at low |
| 3 m | 3-month | -7.42 | -20.2% | -10.47 | +14.8% |
| 6 m | 6-month | -3.73 | -139.1% | -12.50 | +28.6% |
| 1 y | 1-year | -3.73 | -139.1% | -30.61 | +70.9% |
| 3 y | 3-year | -3.73 | -139.1% | -94.71 | +90.6% |
| 5 y | 5-year | -3.73 | -139.1% | -94.71 | +90.6% |
| alltime | all time | -3.73 | -139.1% | -94.71 | +90.6% |
CGON EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -8.92(-29.1%) |
| Date | Value |
|---|---|
| 2024 | -12.58 |
FAQ
- What is CG Oncology, Inc. EV/EBITDA?
- What is the all time high EV/EBITDA for CG Oncology, Inc.?
- What is CGON EV/EBITDA year-to-date change?
- What is CG Oncology, Inc. EV/EBITDA year-on-year change?
What is CG Oncology, Inc. EV/EBITDA?
The current EV/EBITDA of CGON is -8.92
What is the all time high EV/EBITDA for CG Oncology, Inc.?
CG Oncology, Inc. all-time high EV/EBITDA is -3.73
What is CGON EV/EBITDA year-to-date change?
CG Oncology, Inc. EV/EBITDA has changed by +3.66 (+29.09%) since the beginning of the year
What is CG Oncology, Inc. EV/EBITDA year-on-year change?
Over the past year, CGON EV/EBITDA has changed by +20.33 (+69.50%)